Mofegiline
Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.
Link from a Wikipage to another Wikipage
primaryTopic
Mofegiline
Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.
has abstract
Mofegiline (MDL-72,974) is a s ...... sease, but was never marketed.
@en
CAS number
119386-96-8
FDA UNII code
1FMJ6D8Y1B
PubChem
Wikipage page ID
33,869,978
page length (characters) of wiki page
Wikipage revision ID
1,003,174,388
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChemSpiderID
elimination half-life
excretion
Urine
@en
IUPAC name
legal status
Development terminated
@en
PubChem
routes of administration
Oral
@en
SMILES
Fc1cccCCCCN
@en
StdInChIKey
VXLBSYHAEKDUSU-JXMROGBWSA-N
@en
synonyms
MDL-72,974A
@en
wikiPageUsesTemplate
hypernym
comment
Mofegiline (MDL-72,974) is a s ...... sease, but was never marketed.
@en
label
Mofegiline
@en